The loss of the AMBRA1 protein drives the tumor formation in mice and is linked with worse outcomes in some human tumors, and they also found that a lack of AMBRA1 may make some tumors resistant to drugs called CDK4/6 inhibitors, which are a promising new class of cancer treatments [14]. This evidence concerns the gene AMBRA1 and neoplasm.